Epigenetic heterogeneity and state-specific transcriptional programs determine differential drug response in osteosarcoma [RNA-seq]
Single-cell RNA-seq · human · 19 samples
- What it is
- Single-cell RNA-seqGene activity measured in thousands of individual cells, so cell types can be told apart. Read from the summary: GEO's own type field only says 'expression profiling by sequencing', so confirm it in the paper.
- Organism
- Homo sapiens (human)
- Topic
- OsteosarcomaThis series is part of our curated briefing on it.
- Samples
- 19 samples: 19 samples, each with a distinct title — no replicated groupsGroups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
Read the full summary ↓
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE270505_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: Single-cell studies usually ship their counts as 10x files (matrix.mtx, barcodes.tsv, features.tsv), an .h5 file, or an .rds / .h5ad object that Seurat or Scanpy can open. Look for those among the supplementary files.
Also filed as BioProject PRJNA1126765 and SRA study SRP515379. Searching any of these in the dataset finder brings you back here.
Any grouping that defines a comparison lives in the sample characteristics, which GEO records separately from the titles.
How we read this: Read from 19 sample titles: 19 distinct titles with little repetition. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM8345540 OS052_Primary
- GSM8345541 OS152_Metastasis
- GSM8345542 OS186_Metastasis
- GSM8345543 OS525_Metastasis
- GSM8345544 OS526_Primary
- GSM8345545 OS457_Primary
- GSM8345546 c143B_Commercial
- GSM8345547 HOS_Commercial
- GSM8345548 MG63_Commercial
- GSM8345549 MG63.3_Commercial
- GSM8345550 SaOS2_Commercial
- GSM8345551 SJSA_Commercial
- GSM8345552 U2OS_Commercial
- GSM8345553 OS384_Primary
- GSM8345554 OS742_Primary
- GSM8345555 OS766_Metastasis
- GSM8345556 OS774_Primary
- GSM8345557 HuO9_Commercial
- GSM8345558 OS833_Primary
- GSE270506 Epigenetic heterogeneity and state-specific transcriptional programs determine differential drug response in osteosarcoma. 279 samples same disease briefing · shares state-specific, heterogeneity, differential, osteosarcoma, epigenetic, determine, programs
- GSE270502 Epigenetic heterogeneity and state-specific transcriptional programs determine differential drug response in osteosarcoma [ATAC-seq] 87 samples same disease briefing · shares state-specific, heterogeneity, differential, osteosarcoma, epigenetic, determine, programs
- GSE309031 Epigenetic heterogeneity and state-specific transcriptional programs determine differential drug response in osteosarcoma [CUT&Run] 85 samples same disease briefing · shares state-specific, heterogeneity, differential, osteosarcoma, epigenetic, determine, programs
- GSE270503 Epigenetic heterogeneity and state-specific transcriptional programs determine differential drug response in osteosarcoma [Cut&Run] 56 samples same disease briefing · shares state-specific, heterogeneity, differential, osteosarcoma, epigenetic, determine, programs
- GSE308957 Epigenetic heterogeneity and state-specific transcriptional programs determine differential drug response in osteosarcoma. [ATAC-Seq, cell line] 18 samples same disease briefing · shares state-specific, heterogeneity, differential, osteosarcoma, epigenetic, determine, programs
- GSE270504 Epigenetic heterogeneity and state-specific transcriptional programs determine differential drug response in osteosarcoma [snRNAseq + snATACseq] 4 samples same disease briefing · shares state-specific, heterogeneity, differential, osteosarcoma, epigenetic, determine, programs
- GSE307240 Epigenetic and transcriptional heterogeneity define osteosarcoma subtypes and establish targetable vulnerabilities [multiomics] 10 samples same disease briefing · shares heterogeneity, osteosarcoma, epigenetic
- GSE293856 Alphavirus M1 disrupts super-enhancer-driven oncogenic transcription in osteosarcoma [RNA-seq] 32 samples same disease briefing · shares osteosarcoma, rna-seq
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.